February 2008- Volume 4, Issue 2

February 2008

In this Issue

Genomics & Proteomics

New knowledge, new market

New knowledge, new market

Cogenics and the John Innes Centre have introduced a Brassica gene expression array.

Affymetrix offers a new chip off the old block

Affymetrix offers a new chip off the old block

MyGeneChip gives customers access to same advances for model organism studies as they have enjoyed with human arrays.

Multispan and Promega streamlining GPCR screening

Multispan and Promega streamlining GPCR screening

Promega and San Francisco area-based Multispan have agreed to co-develop assay tools for G-protein coupled receptor (GPCR) screening by combining Multispan GPCR cell lines and Promega bioluminescent technologies.

ExonHit\'s fresh faces

ExonHit\'s fresh faces

Company creates two business units to refocus its resources

HIV protein find

HIV protein find

The Harvard Med School RNAi screen nets hundreds of human proteins exploited by HIV

Putting their heads together

Putting their heads together

Rosetta Genomics sparking miRNA-based diagnostics for brain cancer with Henry Ford

Research & Development

Study: Marketing exceeds R&D in U.S. pharma

Study: Marketing exceeds R&D in U.S. pharma

A new study by two York University researchers estimates the U.S. pharmaceutical industry spends almost twice as much on promotion as on R&D.

Slow going for drug development

Slow going for drug development

Tufts study claims complex protocols are slowing up trials.

Myriad steps up

Myriad steps up

In an effort to ramp up discovery and development efforts, Myriad Genetics Inc. announced it has expanded its commercial and clinical capabilities, tapping several industry veterans to spearhead the effort.

TransTech acquires Nordisk programs

TransTech acquires Nordisk programs

To advance its clinical stage drug discovery and development efforts, TransTech Pharma Inc. has taken the wraps off a deal with Novo Nordisk A/S.

Global News

Cutting the cost in Europe

Cutting the cost in Europe

The initiative designed to boost drug development in Europe is cleared.

Working to scuttle schizophrenia

Working to scuttle schizophrenia

Taisho and Pfizer finalize an agreement for novel schizophrenia drug candidate.

Leaving the nest

Leaving the nest

Wockhardt details plans to restructure by spinning off its R&D business.

Proteologics granted first ubiquitin ligase siRNA patent

Proteologics granted first ubiquitin ligase siRNA patent

Proteologics Inc. recently announced that it has been granted U.S. Patent No. 7,268,227 relating to its leading antiviral program.

Sharing the wealth

Sharing the wealth

Amgen partners with Takeda on 13 small molecules in pipeline.

Informatics

The little engine that could

The little engine that could

Compugen’s recent GPCR deal with Merck is helping it to reach “critical mass” in being a discovery and diagnostics leader.

Going out on a LIMS

Going out on a LIMS

Applied Bio and Mettler Toledo team up to simplify workflow and data transfer in labs.

Seeking answers

Seeking answers

Collaboration between Thermo, Matrix combines proteomics search engines.

Eliassen, Medidata to partner in EDC solution

Eliassen, Medidata to partner in EDC solution

Eliassen Group’s eClinical Solutions Division has signed a partnership agreement with Medidata Solutions, a provider of electronic clinical data capture (EDC), management and reporting solutions.

CSS Informatics signs agreement with Nimbus

CSS Informatics signs agreement with Nimbus

PPD Inc. announced that CSS Informatics has entered into a solutions partner agreement with Nimbus Partners.

Automation & Instrumentation

Reshaping for the future

Reshaping for the future

Illumina reorganizes by creating separate life sciences and diagnostics units.

CellzDirect sells

CellzDirect sells

Invitrogen adds to its growing cell products line with $57 million buyout of CellzDirect

Roche, finally, gets Ventana

Roche, finally, gets Ventana

Ventana agrees to become a $3.4 billion part of Roche, but commands a pricey $89.50 per share

IonGate secures E4.6 million, opens U.S. office

IonGate secures E4.6 million, opens U.S. office

Transporter screening specialist IonGate GmbH announced in mid-January that it closed a E4.6 million third round of financing, funding the company says was used to open its first U.S. location in downtown Manhattan and which will also fund the ongoing development and commercialization of its SURFE2R workstation.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN July 2024 Magazine Issue

Latest Issue  

• Volume 20 • Issue 4 • July 2024

July 2024

July 2024 Issue